These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11694869)

  • 1. Presence of lichen planus during a course of interferon alpha-2a therapy for a viral chronic C hepatitis.
    Guijarro Guijarro B; López Sánchez AF; Hernández Vallejo G
    Med Oral; 2001; 6(5):358-63. PubMed ID: 11694869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lichen planus and chronic hepatitis C: exacerbation of the lichen under interferon-alpha-2a therapy.
    Areias J; Velho GC; Cerqueira R; Barbêdo C; Amaral B; Sanches M; Massa A; Saraiva AM
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):825-8. PubMed ID: 8864684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C.
    Nagao Y; Kawaguchi T; Ide T; Kumashiro R; Sata M
    Int J Mol Med; 2005 Feb; 15(2):237-41. PubMed ID: 15647837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
    Protzer U; Ochsendorf FR; Leopolder-Ochsendorf A; Holtermüller KH
    Gastroenterology; 1993 Mar; 104(3):903-5. PubMed ID: 8440441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lichen planus induced by interferon-alpha-2a therapy for chronic active hepatitis C.
    Barreca T; Corsini G; Franceschini R; Gambini C; Garibaldi A; Rolandi E
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):367-8. PubMed ID: 7600144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lichenoid reaction caused by Clopidogrel, a new anti-platelet drug.
    Guijarro Guijarro B; López Sánchez AF
    Med Oral; 2003; 8(1):33-7. PubMed ID: 12556721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis.
    Dalekos GN; Christodoulou D; Kistis KG; Zervou EK; Hatzis J; Tsianos EV
    Eur J Gastroenterol Hepatol; 1998 Nov; 10(11):933-9. PubMed ID: 9872615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral lichen planus induced by interferon-alpha-N1 in a patient with hepatitis C.
    Varela P; Areias J; Mota F; Canelhas A; Sanches M
    Int J Dermatol; 2000 Mar; 39(3):239-40. PubMed ID: 10836860
    [No Abstract]   [Full Text] [Related]  

  • 9. Appearance of oral erosive lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
    Núñez M; Miralles ES; de las Heras ME; Ledo A
    J Dermatol; 1995 Jun; 22(6):461-2. PubMed ID: 7650248
    [No Abstract]   [Full Text] [Related]  

  • 10. [The influence of HCV infection and immunomodulating therapy (interferon-alpha and ribavirin) on the condition of minor salivary glands and oral mucosa].
    Sulka A; Simon K; Jeleń M; Piszko P
    Przegl Epidemiol; 2005; 59(2):455-66. PubMed ID: 16190554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of chronic hepatitis C and lichen planus--in two patients].
    Podányi B; Lengyel G; Kiss A; Szakonyi J; Schaff Z; Fehér J
    Orv Hetil; 2006 Mar; 147(12):547-50. PubMed ID: 16696378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of an initial daily dosing regimen of interferon-alpha-2a in treatment-naive patients with chronic hepatitis C and HCV genotype 1.
    Desch S; Vaeth T; Tamba M; Klinker H; Langmann P
    Eur J Med Res; 2001 Jun; 6(6):242-6. PubMed ID: 11432797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral erosive lichen planus with epidermolytic hyperkeratosis during interferon alfa-2b therapy for chronic hepatitis C virus infection.
    Schlesinger TE; Camisa C; Gay JD; Bergfeld WF
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):1023-5. PubMed ID: 9204077
    [No Abstract]   [Full Text] [Related]  

  • 14. Prompt healing of erosive oral lichen planus lesion after combined corticosteroid treatment with locally injected triamcinolone acetonide plus oral prednisolone.
    Kuo RC; Lin HP; Sun A; Wang YP
    J Formos Med Assoc; 2013 Apr; 112(4):216-20. PubMed ID: 23537868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of interferon-alpha high-dose induction therapy in combination with ribavirin plus amantadine for nonresponder patients with chronic hepatitis C.
    Berg T; Naumann U; Wiedenmann B; Hopf U
    Z Gastroenterol; 2001 Feb; 39(2):145-51. PubMed ID: 11253505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe stomatitis complicating treatment with pegylated-interferon alpha-2a and ribavirin in an HCV-infected patient.
    Borrás-Blasco J; Primo J; Rosique-Robles JD; Casterá E; Abad FJ; Jiménez I
    South Med J; 2008 Jan; 101(1):88-90. PubMed ID: 18176299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xerostomia and lichenoid reaction in a hepatitis C patient treated with interferon-alpha: a case report.
    Ojha J; Bhattacharyya I; Islam N; Cohen DM; Stewart CM; Katz J
    Quintessence Int; 2008 Apr; 39(4):343-8. PubMed ID: 19081905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of therapy-resistant erosive oral lichen planus with extracorporeal photopheresis (ECP)].
    Kunte C; Erlenkeuser-Uebelhoer I; Michelsen S; Scheerer-Dhungel K; Plewig G
    J Dtsch Dermatol Ges; 2005 Nov; 3(11):889-94. PubMed ID: 16232276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary toxicity by pegylated interferon alpha-2a in a patient with chronic hepatitis C].
    Son BK; Sohn JH; Kim TY; Park YK; Jeon YC; Han DS
    Korean J Hepatol; 2007 Mar; 13(1):103-7. PubMed ID: 17380081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C.
    Nouri K; Busso M; Machler BC
    Cutis; 1997 Dec; 60(6):289-90. PubMed ID: 9426968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.